Literature DB >> 8850368

Classification of air density areas in CT-pathologic correlation of pulmonary adenocarcinoma.

N Koizumi1, S Akita, K Sakai, J Oda, H Tsukada, H Usuda, I Emura, M Naito.   

Abstract

Air density areas (ADAs) such as air bronchogram, bubble-like area, and cavity on high resolution computed tomography (HRCT) of pulmonary adenocarcinoma were examined to clarify their pathological implications. Forty-two resected specimens of pulmonary adenocarcinoma were histopathologically examined in correlation with the HRCT findings with particular emphasis on ADAs. Forty-one ADAs observed in 32 of 42 cases with pulmonary adenocarcinoma were classified into three types: air bronchogram type (n = 22), bubble-like area type (n = 12), and cavity type (n = 8). Twenty of 22 air bronchogram ADAs corresponded to bronchi. Nine of 12 bubble-like area ADAs corresponded to bronchioles. Only one of eight cavity-ADAs consisted of necrosis. The classification of ADAs in pulmonary adenocarcinoma is considered to be useful in interpreting HRCT findings of pulmonary nodules.

Entities:  

Mesh:

Year:  1995        PMID: 8850368

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  3 in total

1.  Lingular segmentectomy and left lower lobectomy via unique bronchial dissection.

Authors:  Rumi Higuchi; Takahiro Nakagomi; Daichi Shikata; Yujiro Yokoyama; Toshio Oyama; Taichiro Goto
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Cavitary lung cancer lined with normal bronchial epithelium and cancer cells.

Authors:  Taichiro Goto; Arafumi Maeshima; Yoshitaka Oyamada; Ryoichi Kato
Journal:  J Cancer       Date:  2011-10-04       Impact factor: 4.207

3.  Lung metastasis of transitional cell cancer of the urothelium, with fungus ball-like shadows closely resembling aspergilloma: A case report and review of the literature.

Authors:  Hidehiro Watanabe; Tomonori Uruma; Tokuro Tsunoda; Gen Tazaki; Atsushi Suga; Yusuke Nakamura; Shunsuke Yamada; Takuma Tajiri
Journal:  Oncol Lett       Date:  2014-04-16       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.